Blome, Sandra
Friedrichs, Virginia
Schäfer, Alexander
Beer, Martin
Funding for this research was provided by:
HORIZON EUROPE Framework Programme (101136676 — ASFaVIP)
HORIZON EUROPE Framework Programme (101136676 — ASFaVIP)
HORIZON EUROPE Framework Programme (101136676 — ASFaVIP)
HORIZON EUROPE Framework Programme (101136676 — ASFaVIP)
Article History
Received: 17 April 2025
Accepted: 24 June 2025
First Online: 7 July 2025
Competing interests
: S.B., V.F., A.S., and M.B. work on the EU-funded project ASFaVIP (African Swine Fever attenuated live Vaccines In Pigs), investigating, among others, the vaccine candidate ASFV-G-ΔI177L as a potential live-attenuated vaccine for the European market. None of the authors has a direct financial interest in the candidate ASFV-G-ΔI177L.